摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

goodyeroside A | 211107-44-7

中文名称
——
中文别名
——
英文名称
goodyeroside A
英文别名
(3S)-3-(β-D-glucopyranosyloxy)butanolide;goodyeroside;(4S)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-one
goodyeroside A化学式
CAS
211107-44-7
化学式
C10H16O8
mdl
——
分子量
264.232
InChiKey
MQEPWBMWFIVRPS-MBOSOLAWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    154-155 °C
  • 沸点:
    570.2±50.0 °C(Predicted)
  • 密度:
    1.59±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    126
  • 氢给体数:
    4
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    苯甲酰氯goodyeroside A吡啶 作用下, 反应 17.0h, 以90%的产率得到3-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(3S)-3-hydroxy-γ-butyrolactone
    参考文献:
    名称:
    Synthesis of 3‐O‐β‐D‐Glucopyranosyl‐(3R)‐hydroxybutanolide (Kinsenoside) and 3‐O‐β‐D‐Glucopyranosyl‐(3S)‐hydroxybutanolide (Goodyeroside A)
    摘要:
    The first synthesis of 3-O-beta-D-glucopyranosyl-(3R)-hydroxybutanolide (Kinsenoside) and 3-O-beta-D-glucopyranosyl-(3S)-hydroxybutanolide (Goodyeroside A) is described. The diastereomers of the aglycon in 2-O-beta-D-gulucopyranosyl-1,2,4-butanetriol derivatives, which were separable precursors of Kinsenoside and Goodyeroside A, were synthesized from optically nonactive 1,2,4-butanetriol and alpha-D-glucopyranosyl trichloroacetimidate in excellent yields.
    DOI:
    10.1081/car-200050541
  • 作为产物:
    描述:
    4-甲氧基苯基Β-D-吡喃葡萄糖苷 在 ammonium cerium (IV) nitrate 、 三氟甲磺酸三甲基硅酯 、 palladium 10% on activated carbon 、 氢气 、 sodium hydride 、 溶剂黄1461,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 乙醇二氯甲烷N,N-二甲基甲酰胺乙腈 、 mineral oil 为溶剂, 反应 18.25h, 生成 goodyeroside A
    参考文献:
    名称:
    具有抗炎活性的天然产物人参皂苷类似物的合成
    摘要:
    人参皂苷是来自草药的主要生物活性成分,具有广泛的药理功能。Goodyeroside A 是kinsenoside 的一种差向异构体,仍然很少被探索。在本报告中,我们化学合成了人参皂苷、Goodyeroside A 及其类似物,具有聚糖变异、手性中心的手性反转以及内酰胺对内酯的生物等排置换。在这些化合物中,goodyeroside A 及其甘露糖基对应物表现出优异的抗炎功效。此外,还发现枸杞苷 A 通过抑制 NF-κB 信号通路有效抑制炎症。还探索了构效关系,以进一步开发更有前途的人参皂苷类似物作为候选药物。
    DOI:
    10.1016/j.bmc.2020.115854
点击查看最新优质反应信息

文献信息

  • Design, Synthesis and Hepatoprotective Activity of Analogs of the Natural Product Goodyeroside A
    作者:Feng Zhang、Bei Han、Peng Li、Ziyun Lin、Dali Yin、Yan Li、Jialiang Zhong、Haihong Huang
    DOI:10.3390/molecules18021933
    日期:——
    Goodyeroside A, a natural product isolated from the Goodyera species, possesses significant hepatoprotective activity and has a novel skeleton not previously observed in other synthetic drugs used for the treatment of hepatitis. Herein, we report a highly stereoselective synthesis of goodyeroside A and related analogs with varying substituents at the α position of the carbonyl group to explore the structure-activity relationships of goodyeroside A. The absolute configuration of analog 5d was confirmed by single crystal X-ray analysis. The results from in vitro and in vivo studies indicate that 5a, the fully acetylated compound of goodyeroside A, is worthy of further investigation as a lead to identify novel hepatoprotective agents.
    Goodyeroside A 是一种从 Goodyera 物种中分离出来的天然产物,具有显著的保肝活性,其新颖的骨架是以前在其他用于治疗肝炎的合成药物中未观察到的。在此,我们报告了一种高度立体选择性的合成方法,即在羰基的 α 位上用不同的取代基合成 goodyeroside A 及相关类似物,以探索 goodyeroside A 的结构-活性关系。体外和体内研究的结果表明,5a 是一种完全乙酰化的好耶罗苷 A 化合物,值得进一步研究,以寻找新型保肝药物。
  • Efficient Synthesis of Kinsenoside and Goodyeroside A by a Chemo-Enzymatic Approach
    作者:Yang Zhang、Yihong Xia、Yongji Lai、Fang Tang、Zengwei Luo、Yongbo Xue、Guangmin Yao、Yonghui Zhang、Jinwen Zhang
    DOI:10.3390/molecules191016950
    日期:——
    efficiently by a chemo-enzymatic approach with a total yield of 12.7%. The aglycones, (R)- and (S)-3-hydroxy-γ-butyrolactone, were prepared from D- and L-malic acid by a four-step chemical approach with a yield of 75%, respectively. These butyrolactones were then successfully glycosidated using β-D-glucosidase as a catalyst in a homogeneous organic-water system. Under the optimized enzymatic conditions, the yields
    Kinsenoside (1) 和 goodyeroside A (2) 是两种具有多种生物活性的天然立体异构体,已通过化学酶促方法有效合成,总产率为 12.7%。苷元,(R)-和(S)-3-羟基-γ-丁内酯,分别由D-和L-苹果酸通过四步化学方法制备,产率分别为75%。然后在均相有机水系统中使用 β-D-葡萄糖苷酶作为催化剂成功地糖苷化这些丁内酯。在优化后的酶促条件下,酶促步骤中kinsenoside和goodyeroside A的产率均达到16.8%。
  • Hepatoprotective Aliphatic Glycosides from Three Goodyera Species.
    作者:Xiao-Ming DU、Ning-Yi SUN、Yang CHEN、Nobuto IRINO、Yukihiro SHOYAMA
    DOI:10.1248/bpb.23.731
    日期:——
    Hepatoprotective aliphatic glycosides 3-(S)-3-β-D-glucopyranosyloxybutanolide (1) and its congener, 3-(S)-3-β-D-glucopyranosyloxy-4-hydroxybutanoic acid (2) were isolated as major constituents from the whole plants of three Goodyera species, G. schlechtendaliana REICHB. fil., G. matsumurana SCHLTR. and G. discolor KER-GAWL. The structures of 1 and 2 have been determined by NMR, MS spectroscopic and chemical means. Compound 1 was converted into its methyl ester form (5) during the purification step, when the lactone ring was cleaved by catalysis of silica gel with the CHCl3-MeOH-H2O as a solvent. On the other hand, 1 was obtained in a high yield by the same purification procedure without MeOH. Based on this fact, a simple and economic method for the purification of 1 was confirmed. Compounds 1 and 2 were found to have a hepatoprotective effect on liver injury induced by carbon tetrachloride in primary cultured rat hepatocytes.
    保肝脂肪族糖苷 3-(S)-3-β-D-吡喃葡萄糖氧基丁内酯 (1) 及其同源物 3-(S)-3-β-D-吡喃葡萄糖氧基-4-羟基丁酸 (2) 作为主要成分从三个 Goodyera 物种 G. schlechtendaliana REICHB 的全株。 fil.,G. matsumurana SCHLTR。 G. KER-GAWL 变色。 1和2的结构已通过NMR、MS光谱和化学手段确定。在纯化步骤中,以CHCl3-MeOH-H2O为溶剂,通过硅胶催化,内酯环裂解,化合物1转化为其甲酯形式(5)。另一方面,在没有MeOH的情况下通过相同的纯化程序以高产率获得1。基于这一事实,确定了一种简单且经济的纯化1的方法。发现化合物1和2对原代培养的大鼠肝细胞由四氯化碳引起的肝损伤具有保肝作用。
  • Synthesis of 3‐<i>O</i>‐β‐<scp>D</scp>‐Glucopyranosyl‐(3<i>R</i>)‐hydroxybutanolide (Kinsenoside) and 3‐<i>O</i>‐β‐<scp>D</scp>‐Glucopyranosyl‐(3<i>S</i>)‐hydroxybutanolide (Goodyeroside A)
    作者:Katsuhiko Suzuki、Nobuyuki Suzuki、Masanori Yamaura、Toyokichi Yoshizawa
    DOI:10.1081/car-200050541
    日期:2005.1
    The first synthesis of 3-O-beta-D-glucopyranosyl-(3R)-hydroxybutanolide (Kinsenoside) and 3-O-beta-D-glucopyranosyl-(3S)-hydroxybutanolide (Goodyeroside A) is described. The diastereomers of the aglycon in 2-O-beta-D-gulucopyranosyl-1,2,4-butanetriol derivatives, which were separable precursors of Kinsenoside and Goodyeroside A, were synthesized from optically nonactive 1,2,4-butanetriol and alpha-D-glucopyranosyl trichloroacetimidate in excellent yields.
  • Synthesis of nature product kinsenoside analogues with anti-inflammatory activity
    作者:Wei Song、Yong Sun、Lintao Xu、Yajing Sun、Tianlu Li、Peng Peng、Hongxiang Lou
    DOI:10.1016/j.bmc.2020.115854
    日期:2021.1
    medicine with a broad range of pharmacological functions. Goodyeroside A, an epimer of kinsenoside, remains less explored. In this report we chemically synthesized kinsenoside, goodyeroside A and their analogues with glycan variation, chirality inversion at chiral center(s), and bioisosteric replacement of lactone with lactam. Among these compounds, goodyeroside A and its mannosyl counterpart demonstrated
    人参皂苷是来自草药的主要生物活性成分,具有广泛的药理功能。Goodyeroside A 是kinsenoside 的一种差向异构体,仍然很少被探索。在本报告中,我们化学合成了人参皂苷、Goodyeroside A 及其类似物,具有聚糖变异、手性中心的手性反转以及内酰胺对内酯的生物等排置换。在这些化合物中,goodyeroside A 及其甘露糖基对应物表现出优异的抗炎功效。此外,还发现枸杞苷 A 通过抑制 NF-κB 信号通路有效抑制炎症。还探索了构效关系,以进一步开发更有前途的人参皂苷类似物作为候选药物。
查看更多